Gilead raises prices on top-selling HIV treatments

Gilead raises prices on top-selling HIV treatments

Source: 
Biopharma Dive
snippet: 

Gilead Sciences raised list prices by 4.9% on more than a dozen drugs Saturday, including the bulk of its best-selling HIV medications, the biotech confirmed to BioPharma Dive.